{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:32:45Z","timestamp":1778607165675,"version":"3.51.4"},"reference-count":45,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MRC Confidence in Concept Award"],"award-info":[{"award-number":["MRC Confidence in Concept Award"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["AMS\u2010SGCL8"],"award-info":[{"award-number":["AMS\u2010SGCL8"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["CS\u20102013\u201013\u2010032"],"award-info":[{"award-number":["CS\u20102013\u201013\u2010032"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Type I interferon (\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      ) responses are broadly associated with autoimmune diseases, including systemic lupus erythematosus (\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      ). Given the cardinal role of autoantibodies in\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      , this study was undertaken to investigate whether the findings of a B cell\u2013specific\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      assay correlate with\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      B cells and peripheral blood mononuclear cells (\n                      <jats:styled-content style=\"fixed-case\">PBMC<\/jats:styled-content>\n                      s) were stimulated with type I\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      and type\n                      <jats:styled-content style=\"fixed-case\">II IFN<\/jats:styled-content>\n                      . Gene expression was analyzed, and the expression of pathway\u2010related membrane proteins was determined. A flow cytometry assay for tetherin (\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      317), an\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u2010induced protein ubiquitously expressed on leukocytes, was validated in vitro and then clinically against\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      diagnosis, plasmablast expansion, and the British Isles Lupus Assessment Group (\n                      <jats:styled-content style=\"fixed-case\">BILAG<\/jats:styled-content>\n                      ) 2004 score in a discovery cohort (n = 156\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      patients, 30 rheumatoid arthritis [\n                      <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>\n                      ] patients, and 25 healthy controls). A second, longitudinal validation cohort of 80\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      patients was also evaluated for flare prediction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In vitro, a close cell\u2010specific and dose\u2010response relationship between type I\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u2013responsive genes and cell surface tetherin was observed in all immune cell subsets. Tetherin expression on multiple cell subsets was selectively responsive to stimulation with type I\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      compared to types\n                      <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">III IFN<\/jats:styled-content>\n                      s. In patient samples from the discovery cohort, memory B cell tetherin showed the strongest associations with diagnosis (\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      :healthy control effect size 0.11 [\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003];\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      :\n                      <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>\n                      effect size 0.17 [\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001]), plasmablast numbers in rituximab\u2010treated patients (R = 0.38,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.047), and\n                      <jats:styled-content style=\"fixed-case\">BILAG<\/jats:styled-content>\n                      2004. These associations were equivalent to or stronger than those for\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      score or monocyte tetherin. Memory B cell tetherin was found to be predictive of future clinical flares in the validation cohort (hazard ratio 2.29 [95% confidence interval 1.01\u20134.64];\n                      <jats:italic>P =<\/jats:italic>\n                      0.022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our findings indicate that memory B cell surface tetherin, a B cell\u2013specific\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      assay, is associated with\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      diagnosis and disease activity, and predicts flares better than tetherin on other cell subsets or whole blood assays, as determined in an independent validation cohort.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.41187","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T07:36:02Z","timestamp":1575531362000},"page":"769-779","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["B Cell Tetherin: A Flow Cytometric Cell\u2010Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus"],"prefix":"10.1002","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4791-3475","authenticated-orcid":false,"given":"Yasser M.","family":"El\u2010Sherbiny","sequence":"first","affiliation":[{"name":"University of Leeds, Leeds, UK, Nottingham Trent University School of Science and Technology, Nottingham, UK, and Mansoura University  Mansoura Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-9121","authenticated-orcid":false,"given":"Md Yuzaiful","family":"Md Yusof","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Psarras","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-4755","authenticated-orcid":false,"given":"Elizabeth M. A.","family":"Hensor","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumba Z.","family":"Kabba","sequence":"additional","affiliation":[{"name":"University of Leeds  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Dutton","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa A. A.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and Assiut University  Assiut Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7468-974X","authenticated-orcid":false,"given":"Dirk","family":"Elewaut","sequence":"additional","affiliation":[{"name":"Ghent University  Ghent Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuben","family":"Tooze","sequence":"additional","affiliation":[{"name":"University of Leeds  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Doody","sequence":"additional","affiliation":[{"name":"University of Leeds  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Wittmann","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-8482","authenticated-orcid":false,"given":"Paul","family":"Emery","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Vital","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002795"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32835c7e32"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2011.0071"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2005.08.002"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00198-5"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161451"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24198-1"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3819"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38628"},{"key":"e_1_2_7_11_1","first-page":"311","article-title":"Fluctuations in the gene expression of peripheral blood mononuclear cells between the active and inactive phases of systemic lupus erythematosus","volume":"28","author":"Kawasaki M","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.093146"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067003"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252784499"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000078"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001311"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2014.75.8.440"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600624"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096495"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30466"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206090"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.5.3260"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06553"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31979-1"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201586"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23404"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.02.001"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.10.011"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00427"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0212095"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh624"},{"key":"e_1_2_7_32_1","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen J","year":"1988"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150326"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103720"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211191"},{"key":"e_1_2_7_36_1","first-page":"1662","article-title":"Type I interferon\u2010mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy","volume":"56","author":"Psarras A","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205139"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/prca.200780174"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083776"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210927"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38074"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00208-5"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050630"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.03.019"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22810"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker526"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.41187","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41187","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.41187","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:41:58Z","timestamp":1759952518000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.41187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1002\/art.41187"],"URL":"https:\/\/doi.org\/10.1002\/art.41187","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/554352","asserted-by":"object"}]},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"2018-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}